羽毛球运动中发生手腕和肩袖损伤的相关因素调查

目的：通过对羽毛球爱好者的问卷调查，结合羽毛球项目的运动特点，分析常见的运动损伤部位及其发病原因、处理方法以及预防措施. 方法：调查于2005—03／11在成都医学院体育教研室羽毛球俱乐部完成，对156名羽毛球爱好者进行运动损伤情况凋查，均自愿参加调查。采用问卷调查和专家访谈相结合的方法，主要结合羽毛球项目的运动特点，调查运动损伤的患病率、损伤类型及其受伤原因，分析其常用的处理方法及预防措施。 结果：共发放问卷156份，收回内容详实问卷156份。（1）损伤患病率：运动损伤患病率为78，84％。（2）损伤类型：156名羽毛球爱好者中急性损伤占52、56％，慢性损伤占26，28％。最容易受伤的手腕处受伤患病率为37．39％，其次是肩袖受伤患病率为30．89％。（3）受伤原因：技术动作不规范是运动损伤最主要的原因，占72，35％，而准备活动不充分和身体疲劳分别占63、41％和22．76％. 结论：为有效预防手腕和肩袖损伤，应加强局部肌肉力量训练等防治措施；注意学习和掌握正确的动作技术要领，做好充分的准备活动是十分必要的.     

The need for a revival of psychoanalytic investigations into premature ejaculation

Although psychoanalysis was the first-choice treatment for premature ejaculation (PE) between 1920 and 1960, hardly any reports on its efficacy have been published. Moreover, a scientific debate about its findings has never been fully developed. The recent progress that has been made in the classification of three different PE syndromes creates a new opportunity for psychoanalytic investigations of men with complaints of PE, distinguished by the actual duration of their intravaginal ejaculation latency time (IELT). The term premature-like ejaculatory dysfunction has been introduced to distinguish men with self-perceived PE at normal and long IELT durations from those men with lifelong, acquired and normal variable PE. Psychoanalytic research may contribute to a better understanding of the consequences of objective early ejaculations on the unconscious mental life of men with the four forms of PE. By integrating neurobiological, clinical and epidemiological data of ejaculatory performance, a revival of psychoanalytic research of PE in the four distinct, classified PE groups, will probably contribute to a deeper insight in to the unconscious mental life of men affected by PE.     

Pharmacologic treatment of fibromyalgia

Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.